Carbapenemase Gene Transmission in CREC, Guangdong

Carbapenem-resistant Enterobacter cloacae (CREC) is an important component of the broader carbapenem-resistant Enterobacteriaceae problem. Its clinical significance is not determined only by whether a strain resists carbapenems; the location of carbapenemase-encoding genes (CEGs), the genetic elements surrounding them, and the ability of strains to exchange those determinants all influence transmission risk. The 2025 study by Chen, Yan, Liu, and colleagues addresses these connected questions using isolates collected from eight teaching hospitals in Guangdong province, China, between December 2022 and June 2024. The reference study is particularly useful because it combines molecular epidemiology with functional transfer experiments rather than treating resistance prevalence as an isolated endpoint.

Study Background and Research Question

The authors frame their work against the increased complexity of antimicrobial resistance during and after the COVID-19 pandemic. Greater antibiotic exposure, disrupted healthcare pathways, and complicated infections may create conditions in which resistant organisms are selected and disseminated. However, the pandemic context does not by itself explain how a resistance determinant moves through a hospital network. A more informative analysis must distinguish chromosomal carriage from plasmid carriage, determine whether a gene can transfer to a recipient bacterium, and assess whether apparently unrelated isolates share related genetic backgrounds.

The central research question was therefore multidimensional: which CEGs occur in CREC collected from hospitals in Guangdong; are these genes located on chromosomes, plasmids, or both; how efficiently can they transfer by conjugation; which mobile genetic elements accompany them; and do genotyping data indicate local clonal expansion or dissemination across departments and institutions? This design also allowed the investigators to compare antimicrobial susceptibility between CEG-positive and CEG-negative isolates.

Key Innovation from the Reference Study

The principal innovation is the integration of gene location, transferability, resistance phenotype, mobile-element context, and strain relatedness in a single regional dataset. Many surveillance reports identify carbapenemase genes but stop at prevalence estimates. Here, plasmid elimination and PCR were used to investigate physical localization, conjugation was used to test transfer potential, and ERIC-PCR with NTSYS analysis was used to examine strain-level relationships. These approaches address different biological layers: localization suggests persistence potential, conjugation tests horizontal mobility under laboratory conditions, and fingerprinting helps assess vertical or clonal dissemination.

The study also avoids an overly narrow focus on a single hospital ward. Isolates came from eight teaching hospitals, and related genotypes were found in different departments and hospitals. That multicenter perspective is important for infection-control interpretation because a resistance gene can spread through mobile plasmids even when the host strain changes, while a successful clone can disseminate without frequent gene exchange. The resulting framework is more informative than a simple list of resistant species or antibiotic results.

Methods and Experimental Design Insights

The investigators analyzed 54 CREC isolates. Variable-temperature sodium dodecyl sulfate plasmid elimination was paired with PCR to infer whether target carbapenemase genes were plasmid-borne or chromosomal. Broth microdilution provided the antimicrobial susceptibility data. Plasmid conjugation experiments, followed by PCR analysis of putative transconjugants, tested whether CEGs could move into a recipient strain. The authors additionally characterized six mobile genetic elements and used ERIC-PCR to group isolates into genotypes with NTSYS software.

This layered design is valuable for researchers planning Gram-negative bacterial infection research. A susceptibility assay alone cannot establish transmission potential, and PCR detection alone cannot identify whether a gene is readily mobilizable. Conversely, a positive conjugation result does not demonstrate transmission in patients. The strength of the design comes from interpreting these outputs together.

Protocol Parameters

• Isolate frame: Analyze CREC recovered from eight teaching hospitals in Guangdong during December 2022–June 2024, as reported in the reference study.
• Gene localization: Use plasmid elimination followed by target-specific PCR to compare plasmid-associated and chromosomal CEG signals; the exact temperature and SDS conditions should be taken from the full methods rather than inferred from the summary.
• Susceptibility testing: Apply broth microdilution to compare CEG-positive and CEG-negative groups across the reported antimicrobial panel. This is a literature-backed workflow parameter, whereas inoculum preparation and interpretive breakpoints should follow the laboratory’s validated standard.
• Transfer assessment: Pair plasmid conjugation with PCR confirmation of transconjugants. A workflow recommendation is to include recipient-only, donor-only, and selection-control conditions so that apparent transfer is not confused with donor carryover.
• Genetic relatedness: Use ERIC-PCR and computational clustering as a screening-level fingerprinting approach. For outbreak confirmation or plasmid architecture, whole-genome sequencing would provide higher resolution than the reported fingerprinting method.

Core Findings and Why They Matter

High CEG prevalence and dominance of blaNDM-1

CEGs were detected in 46 of 54 isolates, corresponding to 85.19% of the collection, according to the published results. The most prominent determinant was blaNDM-1. Eighteen isolates, or 33.33%, carried blaNDM-1 on both chromosomes and plasmids, while 25 isolates, or 46.30%, carried it exclusively on plasmids. Two isolates carried only blaIMP on plasmids, and one carried both blaNDM-1 and blaKPC-2 on plasmids.

This distribution matters because plasmid localization can provide a route for resistance to move between bacterial cells, while dual chromosomal and plasmid carriage may create opportunities for persistence in different genetic contexts. The findings do not mean that every plasmid is equally mobile or that every blaNDM-1-positive strain will spread clinically. They do show that plasmid-associated blaNDM-1 was common enough in this collection to warrant targeted surveillance and transfer testing.

Resistance phenotype associated with CEG carriage

The CEG-positive group had significantly higher resistance rates to imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin than the CEG-negative group, with statistical significance reported at P < 0.05 in the study analysis. The result supports an association between carbapenemase carriage and multidrug resistance, but it should not be interpreted as proof that CEGs alone caused every phenotype. Permeability changes, efflux, additional beta-lactamases, and unrelated resistance determinants may also contribute.

The ceftazidime/avibactam result is especially relevant to experimental interpretation. It indicates a difference between gene-defined groups in this isolate set, not universal susceptibility or resistance across CREC populations. Researchers should therefore retain isolate-specific testing and avoid using one antimicrobial result as a surrogate for the complete resistance genotype.

Efficient experimental transfer of CEGs

Conjugation experiments produced successful CEG transfer for 44 of 46 CEG-positive isolates, or 95.65%, as reported by Chen et al. Transfer was observed for blaNDM-1 in 42 of 44 tested cases, for blaIMP in both of two cases, and for blaKPC-2 in none of the single tested cases. These denominators are important: the apparent 100% blaIMP rate derives from only two isolates, while the absence of blaKPC-2 transfer is based on one isolate and cannot establish a general property of that gene.

Even with those qualifications, the findings demonstrate substantial horizontal-transfer capacity under the experimental conditions. This complements the evidence for vertical dissemination: the combination of plasmid mobility and related strain fingerprints suggests that CREC transmission may involve both gene exchange and expansion of successful lineages.

Mobile elements and strain structure

Six mobile genetic elements were identified. ISEcp1 was the most prevalent, occurring in 47 of 54 isolates, or 87.04%, and the most common pattern involved four mobile elements simultaneously, observed in 22 isolates, or 40.74%, according to the reference paper. These data provide context for why resistance determinants may persist in changing bacterial backgrounds, although the presence of an element does not by itself prove that it mobilized a particular CEG in vivo.

ERIC-PCR divided the 54 isolates into 17 genotypes. Types E and G were each found in 11 isolates, or 20.37%, and were recovered from different departments in five hospitals. Two type E isolates had a Dice coefficient of 100%. The findings point to both broad distribution and possible local clonal relationships, but ERIC-PCR should be regarded as a lower-resolution method than genome-wide sequencing for confirming transmission chains.

Epidemiological distribution

The highest detection frequencies occurred among male patients, older patients, respiratory-medicine cases, and sputum specimens: 35 isolates, or 64.81%, were from men; 39, or 72.22%, were from elderly patients; 11, or 20.37%, were associated with respiratory medicine; and 18, or 33.33%, came from sputum. These figures describe the composition of the study collection rather than population-adjusted risk. Nevertheless, the respiratory and sputum signal highlights why specimen-specific surveillance and careful distinction between colonization and infection are essential.

Comparison with Existing Internal Articles

The internal article Transmission Dynamics of Carbapenemase Genes in CREC in China provides a concise overview of the same multicenter investigation, emphasizing plasmid-associated blaNDM-1, multidrug resistance, and horizontal gene transfer. The present analysis adds a methods-focused interpretation: it explains why the combination of plasmid elimination, conjugation, mobile-element profiling, and ERIC-PCR is more informative than any single assay. It also highlights denominator limitations and the distinction between laboratory transfer and clinical transmission, points that are important when adapting the findings to antimicrobial-resistance surveillance or model development.

Limitations and Transferability

The sample size was limited to 54 isolates from eight teaching hospitals, and the collection was not presented as a population-based estimate of CREC prevalence. The study therefore cannot determine the incidence of CEG-positive CREC across Guangdong or establish patient-level risk factors. The reported sex, age, department, and specimen distributions are descriptive and may reflect referral patterns, sampling practices, or the structure of participating hospitals.

Gene localization based on plasmid elimination and PCR is informative but less definitive than complete genome sequencing. It may not resolve multiple plasmids, integrated plasmid fragments, or complex chromosomal insertions. Similarly, conjugation measures transfer under selected laboratory conditions. It does not establish transfer frequency in patients, environmental reservoirs, or the relative contribution of antibiotic exposure and healthcare contact.

The pandemic interpretation also requires caution because the reported collection spans 2022–2024 without a matched pre-pandemic comparator in the condensed findings. A longitudinal design with antibiotic-use data, ward-level movement, environmental sampling, long-read plasmid sequencing, and patient outcomes would better separate temporal change from persistent regional patterns. Finally, ERIC-PCR can identify broad relatedness but should be supplemented by whole-genome sequencing when making high-consequence outbreak decisions.

Why this cross-domain matters, maturity, and limitations

Connecting hospital molecular surveillance with laboratory infection models is useful because the study identifies concrete variables to reproduce: plasmid carriage, CEG transfer, multidrug-resistant phenotypes, and respiratory specimen context. The bridge remains at an early translational stage. A laboratory model can test selection, transfer, or antimicrobial response, but it cannot automatically reproduce hospital ecology or patient treatment outcomes. Any extension from the Guangdong dataset to another organism, region, or respiratory disease model should therefore be treated as hypothesis generation and validated with local isolates and susceptibility data.

Research Support Resources

For Gram-negative bacterial infection research, researchers can use Ceftazidime (SKU B3539) to support carefully controlled antimicrobial-comparison workflows. It is a third-generation cephalosporin with documented aerobic Gram-negative activity, including activity relevant to Pseudomonas aeruginosa infection research; it should not be used as a substitute for carbapenemase genotyping or isolate-specific susceptibility testing. Product preparation and frozen-storage guidance should be followed for reproducible assays.

These applications may support translational studies related to the treatment of bacterial pneumonia or treatment of bacterial bronchitis, but the Guangdong study itself does not establish a clinical regimen for either condition. Its strongest practical message is methodological: combine phenotype, gene location, transfer experiments, mobile-element analysis, and strain relatedness before drawing conclusions about resistance transmission.